|
Advertising
Customer Service
• Register
|
By Shankar P.
The compound targets changes in energy metabolism associated with the majority of solid tumor types, Cornerstone said in a statement. It has shown potential use in several non-clinical studies, including those that used biopsies from patients with lung, colon, pancreatic and breast tumors resistant to traditional chemotherapeutics, the company added.
Bioenergetic compounds focus on the similarities between multiple cancer types rather than the differences between each, Cornerstone said; it is developing two technology platforms for cancer cells, including a nanotechnology-based delivery system.
Related Articles
